Get started
Author

Anne Doé de Maindreville

Observed names: A. Doe De Maindreville, A. Doe de Maindreville, A. Doé De Maindreville, A. Doé de Maindreville, Anne De Maindreville, Anne Doe De Maindreville, Anne Doe de Maindreville, Anne Doé De Maindreville, de Maindreville, Anne Doé
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris-Est Créteil, École Normale Supérieure - PSL, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Centre de Recherche en Sciences et Technologies de l'Information et de la Communication, Centre Hospitalier Universitaire de Reims, Hôpital Avicenne, Institut du Cerveau, Institut Mondor de Recherche Biomédicale, Hôpital Maison Blanche, French Clinical Research Infrastructure Network, Université Pierre-et-Marie-Curie, CIC Pitié Neurosciences, Université de Reims Champagne-Ardenne
ORCID: 0000-0003-3944-498X
Observed ORCID: 0000-0003-3944-498X
OpenAlex ID: A5008004529
Hallucinations in Parkinson's disease: A follow‐up study
2004 · Anne Doé de Maindreville, Gilles Fénelon, et al. · Movement Disorders · 119
Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: Improvement on switching the target
2008 · Delphine Raucher-Chéné, Claire-Lise Charrel, et al. · Journal of the Neurological Sciences · 103
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia
2016 · Elodie Hainque, Marie Vidailhet, et al. · Neurology · 82
Recognition of facial and musical emotions in P arkinson's disease
2012 · A. Saenz, A. Doé de Maindreville, et al. · European Journal of Neurology · 41
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
2021 · Margherita Fabbri, Clémence Leung, et al. · Parkinsonism & Related Disorders · 28
PDF
Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?
2019 · Louise-Laure Mariani, Mohamed Doulazmi, et al. · Parkinsonism & Related Disorders · 20
PDF
Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
2025 · Aymeric Lanore, Christelle Tesson, et al. · npj Parkinson s Disease · 14
PDF
Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS ‐Park Cohort
2025 · Clément Desjardins, Paulo André Dias Bastos, et al. · Movement Disorders Clinical Practice · 12
PDF
Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study
2023 · Ana Marques, Elise Macias, et al. · Journal of Neurology · 11
“Accidental, really?” Attributional bias in patients with Parkinson's disease
2021 · Léa Decombe, Audrey Henry, et al. · Parkinsonism & Related Disorders · 9
PDF
Amantadine use in the French prospective NS-Park cohort
2024 · Margherita Fabbri, Vanessa Rousseau, et al. · Journal of Neural Transmission · 7
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
2022 · Laila Khedher, Jean-Marie Bonny, et al. · NeuroImage Clinical · 7
PDF
Survey on Parkinson’s Disease Diagnosis Impact: Patients, Caregivers and Health Care Professionals’ Perspectives
2024 · Stela Dodaj, Margherita Fabbri, et al. · Journal of Clinical Medicine · 4
Evidence of presynaptic dopaminergic dysfunction in acute methanol intoxication
2017 · A. Doé de Maindreville, S. Bakchine, et al. · Revue Neurologique · 4
Motor and Non-motor Complications Following Different Early Therapies in Parkinson’s Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort
2025 · Aymeric Lanore, Edouard Januel, et al. · CNS Drugs · 3
PDF
Systemic Sarcoidosis Mimicking a Behavioural Variant of Frontotemporal Dementia
2015 · Anne De Maindreville, Line Bedos, et al. · Case Reports in Neurological Medicine · 3
PDF
Encéphalopathie de Hashimoto : une cause rare d’état de mal épileptique
2013 · A. Doe De Maindreville, C. Gombert, et al. · Revue Neurologique · 3
One‐Year Substantia Nigra R2* Changes across Parkinson's Disease Stages
2026 · Calvin Coussediere, Bruno Pereira, et al. · Movement Disorders · 1
PDF
Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts
2026 · Raquel Barbosa, Paulo Bastos, et al. · Neurology
No role of intronic expansions in HSF1 for essential tremor in Europe
2026 · Jean-Loup Méreaux, Thomas Wirth, et al. · Brain
Author Correction: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
2025 · Aymeric Lanore, Christelle Tesson, et al. · npj Parkinson s Disease
PDF
Motor complications and postural abnormalities interplay in Parkinson's disease
2025 · Margherita Fabbri, Aymeric Lanore, et al. · Parkinsonism & Related Disorders
Disappearance of anti-thyroglobulin antibodies from the cerebrospinal fluid in parallel with neurological improvement during treatment for Hashimoto’s encephalopathy
2022 · Maïwen Petithomme-Nanrocki, Aurélie Brunet, et al. · Annales de biologie clinique
PDF
Troubles du sommeil, mouvements anormaux, cognition, verticalité : anti-IgLON5 ?
2022 · Clément Prévost, Anne Doé de Maindreville, et al. · Revue Neurologique
20 cas cliniques en neuropsychologie
2021 · Nathalie Ehrlé, Anne Doé de Maindreville, et al. · Dunod eBooks
Works count: 38
Citation count: 471
H-index: 9
I10-index: 9
Year
Topic
Type